Free Trial

Agape ATP (ATPC) Competitors

Agape ATP logo
$1.34 -0.04 (-2.90%)
Closing price 07/3/2025 01:21 PM Eastern
Extended Trading
$1.38 +0.04 (+2.91%)
As of 04:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ATPC vs. TOI, CORBF, DCGO, XGN, EUDA, SERA, NAKA, KDLY, QIPT, and OPGN

Should you be buying Agape ATP stock or one of its competitors? The main competitors of Agape ATP include Oncology Institute (TOI), Global Cord Blood (CORBF), DocGo (DCGO), Exagen (XGN), EUDA Health (EUDA), Sera Prognostics (SERA), KindlyMD (NAKA), Kindly MD (KDLY), Quipt Home Medical (QIPT), and OpGen (OPGN). These companies are all part of the "healthcare" industry.

Agape ATP vs. Its Competitors

Oncology Institute (NASDAQ:TOI) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

Oncology Institute has a net margin of -15.38% compared to Agape ATP's net margin of -191.34%. Agape ATP's return on equity of -30.95% beat Oncology Institute's return on equity.

Company Net Margins Return on Equity Return on Assets
Oncology Institute-15.38% -445.02% -34.13%
Agape ATP -191.34%-30.95%-27.00%

Oncology Institute has a beta of 0.02, meaning that its stock price is 98% less volatile than the S&P 500. Comparatively, Agape ATP has a beta of -0.98, meaning that its stock price is 198% less volatile than the S&P 500.

In the previous week, Oncology Institute had 2 more articles in the media than Agape ATP. MarketBeat recorded 2 mentions for Oncology Institute and 0 mentions for Agape ATP. Oncology Institute's average media sentiment score of 0.00 equaled Agape ATP'saverage media sentiment score.

Company Overall Sentiment
Oncology Institute Neutral
Agape ATP Neutral

Agape ATP has lower revenue, but higher earnings than Oncology Institute. Oncology Institute is trading at a lower price-to-earnings ratio than Agape ATP, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oncology Institute$393.41M0.56-$64.66M-$0.70-3.52
Agape ATP$1.32M50.77-$2.47M-$0.60-2.23

Oncology Institute currently has a consensus price target of $7.00, suggesting a potential upside of 183.98%. Given Oncology Institute's stronger consensus rating and higher possible upside, analysts plainly believe Oncology Institute is more favorable than Agape ATP.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oncology Institute
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Agape ATP
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

36.9% of Oncology Institute shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 8.5% of Oncology Institute shares are held by company insiders. Comparatively, 9.7% of Agape ATP shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Oncology Institute beats Agape ATP on 8 of the 15 factors compared between the two stocks.

Get Agape ATP News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATPC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATPC vs. The Competition

MetricAgape ATPMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$67.01M$10.41B$5.53B$9.02B
Dividend YieldN/A2.07%5.22%3.99%
P/E Ratio-2.2317.0327.7520.25
Price / Sales50.7729.81427.83119.26
Price / CashN/A23.9726.2128.59
Price / Book2.793.668.045.65
Net Income-$2.47M$235.43M$3.18B$249.15M
7 Day Performance1.52%1.53%2.88%2.91%
1 Month Performance-12.42%1.07%1.66%4.11%
1 Year Performance-66.53%-10.17%34.51%20.98%

Agape ATP Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATPC
Agape ATP
N/A$1.34
-2.9%
N/A-66.5%$67.01M$1.32M-2.2340Gap Down
TOI
Oncology Institute
1.3736 of 5 stars
$2.20
+7.3%
$7.00
+218.2%
+384.8%$182.93M$393.41M-3.14660
CORBF
Global Cord Blood
N/A$1.45
-3.3%
N/AN/A$176.25M$196.12M0.001,200Gap Down
DCGO
DocGo
2.3126 of 5 stars
$1.52
-3.2%
$3.56
+134.2%
-45.7%$160.11M$616.55M-76.004,407Positive News
XGN
Exagen
3.6461 of 5 stars
$6.99
+0.1%
$7.50
+7.3%
+287.1%$148.67M$55.64M-8.32220
EUDA
EUDA Health
N/A$3.42
-4.5%
N/A-10.0%$133.02M$4.01M0.002Gap Up
SERA
Sera Prognostics
1.353 of 5 stars
$2.59
-6.5%
N/A-53.7%$104.35M$80K-2.76120Gap Down
High Trading Volume
NAKA
KindlyMD
N/A$13.61
-1.7%
N/AN/A$83.48M$2.72M-17.68N/APositive News
KDLY
Kindly MD
N/A$13.85
-3.0%
N/A+466.7%$83.38M$2.47M-17.98N/A
QIPT
Quipt Home Medical
2.37 of 5 stars
$1.75
-2.2%
$2.85
+62.9%
-40.7%$77.76M$245.91M-8.331,200
OPGN
OpGen
N/A$4.76
-0.4%
N/A+77.2%$47.92M$2.67M0.00100

Related Companies and Tools


This page (NASDAQ:ATPC) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners